Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb 20;13(3):530.
doi: 10.3390/biomedicines13030530.

Cannabinoids in Chronic Pain Management: A Review of the History, Efficacy, Applications, and Risks

Affiliations
Review

Cannabinoids in Chronic Pain Management: A Review of the History, Efficacy, Applications, and Risks

Brooks W Johnson et al. Biomedicines. .

Abstract

Background/Objectives: Chronic pain remains a pervasive and challenging public health issue, often resistant to conventional treatments such as opioids, which carry substantial risks of dependency and adverse effects. Cannabinoids, bioactive compounds derived from the Cannabis sativa plant and their synthetic analogs, have emerged as a potential alternative for pain management, leveraging their interaction with the endocannabinoid system to modulate pain and inflammation. Methods: The current, evolving literature regarding the history, efficacy, applications, and safety of cannabinoids in the treatment of chronic pain was reviewed and summarized to provide the most current review of cannabinoids. Results: Evidence suggests that cannabinoids provide moderate efficacy in managing neuropathic pain, fibromyalgia, cancer-related pain, and multiple sclerosis-related spasticity. Patient-reported outcomes further indicate widespread perceptions of cannabinoids as a safer alternative to opioids, with potential opioid-sparing effects. However, the quality of existing evidence is limited by small sample sizes and methodological inconsistencies. Regulatory barriers, including the classification of cannabis as a Schedule I substance in the United States, continue to hinder robust research and clinical integration. Moreover, the risks associated with cannabinoids, such as psychiatric effects, addiction potential, and drug interactions, necessitate cautious application. Conclusions: Cannabinoids represent a promising, albeit complex, alternative for chronic pain management, particularly given the limitations and risks of traditional therapies such as opioids. However, significant deficiencies remain in the research. While smaller trials and systematic reviews indicate therapeutic potential, the quality of evidence is often low due to limited sample sizes, short study durations, and methodological inconsistencies. Large-scale, randomized controlled trials with long-term follow-up are urgently needed to confirm efficacy and safety across diverse patient populations and pain etiologies.

Keywords: cannabinoids; chronic pain; fibromyalgia; headache; marijuana; neuropathy; tetrahydrocannabinol.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Proposed mechanism of cannabinoids in pain management.

References

    1. Mills S.E.E., Nicolson K.P., Smith B.H. Chronic pain: A review of its epidemiology and associated factors in population-based studies. Br. J. Anaesth. 2019;123:e273–e283. doi: 10.1016/j.bja.2019.03.023. - DOI - PMC - PubMed
    1. Disease G.B.D., Injury I., Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211–1259. doi: 10.1016/S0140-6736(17)32154-2. - DOI - PMC - PubMed
    1. Janevic M.R., McLaughlin S.J., Heapy A.A., Thacker C., Piette J.D. Racial and Socioeconomic Disparities in Disabling Chronic Pain: Findings From the Health and Retirement Study. J. Pain. 2017;18:1459–1467. doi: 10.1016/j.jpain.2017.07.005. - DOI - PMC - PubMed
    1. Judd D., King C.R., Galke C. The Opioid Epidemic: A Review of the Contributing Factors, Negative Consequences, and Best Practices. Cureus. 2023;15:e41621. doi: 10.7759/cureus.41621. - DOI - PMC - PubMed
    1. Gomes T., Tadrous M., Mamdani M.M., Paterson J.M., Juurlink D.N. The Burden of Opioid-Related Mortality in the United States. JAMA Netw. Open. 2018;1:e180217. doi: 10.1001/jamanetworkopen.2018.0217. - DOI - PMC - PubMed

LinkOut - more resources